NEW YORK (GenomeWeb) – Effective vaccination against malaria could saves hundreds of thousands of lives each year, particularly among children in sub-Saharan Africa. An existing malaria vaccine does not provide full protection, but a research team at the University of Maryland hopes to change that.
In collaboration with vaccine developer Sanaria, the team will conduct a sequencing-based genome-wide study on samples from vaccine trials to discover loci yielding protection against the deadly disease.
Only $95 for the first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.